Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-12-15 5:14 pm Purchase | 13D | CARTESIAN THERAPEUTICS, INC. C RNAC | SPRINGER TIMOTHY A | 32,451,726 27.8% | 3,821,273 (+13.35%) | View |
2021-05-27 4:11 pm Purchase | 13D | CARTESIAN THERAPEUTICS, INC. C RNAC | SPRINGER TIMOTHY A | 28,630,453 25.3% | 4,693,479 (+19.61%) | View |
2021-02-16 12:03 pm Purchase | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | Mangrove Partners Master Fund Ltd. | 3,332,918 3% | 3,332,918 (New Position) | View |
2021-02-12 5:19 pm Sale | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | EcoR1 Capital LLC | 2,298,850 2.1% | -4,597,701 (-66.67%) | View |
2021-02-02 3:13 pm Purchase | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | BlackRock Inc. BLK | 5,474,324 5.1% | 5,474,324 (New Position) | View |
2020-10-23 5:19 pm Purchase | 13D | CARTESIAN THERAPEUTICS, INC. C RNAC | SPRINGER TIMOTHY A | 23,936,974 22.3% | 5,532,388 (+30.06%) | View |
2020-10-15 10:10 am Purchase | 13D | CARTESIAN THERAPEUTICS, INC. C RNAC | SPRINGER TIMOTHY A | 18,404,586 17.2% | 3,472,097 (+23.25%) | View |
2020-08-10 08:40 am Purchase | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | Swedish Orphan Biovitrum AB (publ) | 5,416,390 6.2% | 5,416,390 (New Position) | View |
2020-06-26 4:31 pm Sale | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | Vivo Capital IX LLC | 1,369,863 1.6% | -5,102,560 (-78.84%) | View |
2020-02-12 4:42 pm Purchase | 13D | CARTESIAN THERAPEUTICS, INC. C RNAC | Polaris Venture Partners V L.P. | 2,789,889 3.2% | 10,000 (+0.36%) | View |
2020-02-11 12:44 pm Purchase | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | WASATCH ADVISORS LP | 4,416,827 9.2% | 4,416,827 (New Position) | View |
2020-02-10 4:08 pm Sale | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | Man Group plc | 861,145 1% | -2,811,473 (-76.55%) | View |
2020-02-05 4:36 pm Sale | 13D | CARTESIAN THERAPEUTICS, INC. C RNAC | ORBIMED ADVISORS LLC | 2,779,064 3.2% | -100,000 (-3.47%) | View |
2020-01-13 1:27 pm Purchase | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | MANGROVE PARTNERS IM LLC | 7,881,774 8.9% | 7,881,774 (New Position) | View |
2020-01-06 10:00 pm Purchase | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | BIOTECHNOLOGY VALUE FUND L P | 4,926,108 5.6% | 4,926,108 (New Position) | View |
2020-01-06 5:11 pm Purchase | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | EcoR1 Capital LLC | 6,896,551 7.8% | 6,896,551 (New Position) | View |
2020-01-02 4:51 pm Purchase | 13D | CARTESIAN THERAPEUTICS, INC. C RNAC | SPRINGER TIMOTHY A | 14,932,489 17% | 5,911,330 (+65.53%) | View |
2019-12-30 4:20 pm Purchase | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | Vivo Capital IX LLC | 6,472,423 7.5% | 6,472,423 (New Position) | View |
2019-12-16 8:43 pm Purchase | 13D | CARTESIAN THERAPEUTICS, INC. C RNAC | SPRINGER TIMOTHY A | 9,021,159 18.7% | 1,237,028 (+15.89%) | View |
2019-11-13 12:57 pm Purchase | 13D | CARTESIAN THERAPEUTICS, INC. C RNAC | ORBIMED ADVISORS LLC | 2,879,064 5.97% | 1,300,000 (+82.33%) | View |